Related references
Note: Only part of the references are listed.Cell-autonomous and cell non-autonomous downregulation of tumor suppressor DAB2IP by microRNA-149-3p promotes aggressiveness of cancer cells
Arianna Bellazzo et al.
CELL DEATH AND DIFFERENTIATION (2018)
Cancer incidence and mortality in China, 2014
Wanqing Chen et al.
CHINESE JOURNAL OF CANCER RESEARCH (2018)
MicroRNA-129-5p Regulates Glycolysis and Cell Proliferation by Targeting the Glucose Transporter SLC2A3 in Gastric Cancer Cells
Di Chen et al.
FRONTIERS IN PHARMACOLOGY (2018)
The p53 Tumor Suppressor in the Control of Metabolism and Ferroptosis
Keerthana Gnanapradeepan et al.
FRONTIERS IN ENDOCRINOLOGY (2018)
Targeting SLC25A10 alleviates improved antioxidant capacity and associated radioresistance of cancer cells induced by chronic-cycling hypoxia
Julian Hlouschek et al.
CANCER LETTERS (2018)
Poly(ADP-ribose) polymerase 1 is necessary for coactivating hypoxia-inducible factor-1-dependent gene expression by Epstein-Barr virus latent membrane protein 1
Michael Hulse et al.
PLOS PATHOGENS (2018)
The microRNA-182-PDK4 axis regulates lung tumorigenesis by modulating pyruvate dehydrogenase and lipogenesis
G. Li et al.
ONCOGENE (2017)
MicroRNAs are important regulators of drug resistance in colorectal cancer
Yang Zhang et al.
BIOLOGICAL CHEMISTRY (2017)
Potent effects of dioscin against pancreatic cancer via miR-149-3P-mediated inhibition of the Akt1 signalling pathway
Lingling Si et al.
BRITISH JOURNAL OF PHARMACOLOGY (2017)
Pharmacologic resistance in colorectal cancer: a review
William A. Hammond et al.
THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY (2016)
Activation of mitochondrial oxidation by PDK2 inhibition reverses cisplatin resistance in head and neck cancer
Jong-Lyel Roh et al.
CANCER LETTERS (2016)
Tumor Interferon Signaling Regulates a Multigenic Resistance Program to Immune Checkpoint Blockade
Joseph L. Benci et al.
CELL (2016)
Dichloroacetate alters Warburg metabolism, inhibits cell growth, and increases the X-ray sensitivity of human A549 and H1299 NSC lung cancer cells
Kah Tan Allen et al.
FREE RADICAL BIOLOGY AND MEDICINE (2015)
MicroRNA-124 Reduces the Pentose Phosphate Pathway and Proliferation by Targeting PRPS1 and RPIA mRNAs in Human Colorectal Cancer Cells
Zhaoping Qiu et al.
GASTROENTEROLOGY (2015)
MiR-199a-5p is negatively associated with malignancies and regulates glycolysis and lactate production by targeting hexokinase 2 in liver cancer
Weijie Guo et al.
HEPATOLOGY (2015)
A phase I open-labeled, single-arm, dose-escalation, study of dichloroacetate (DCA) in patients with advanced solid tumors
Quincy Siu-Chung Chu et al.
INVESTIGATIONAL NEW DRUGS (2015)
MicroRNAs: New Biomarkers for Diagnosis, Prognosis, Therapy Prediction and Therapeutic Tools for Breast Cancer
Gloria Bertoli et al.
THERANOSTICS (2015)
Increased drug resistance is associated with reduced glucose levels and an enhanced glycolysis phenotype
B. Bhattacharya et al.
BRITISH JOURNAL OF PHARMACOLOGY (2014)
Dichloroacetate attenuates hypoxia-induced resistance to 5-fluorouracil in gastric cancer through the regulation of glucose metabolism
Yi Xuan et al.
EXPERIMENTAL CELL RESEARCH (2014)
Activating oxidative phosphorylation by a pyruvate dehydrogenase kinase inhibitor overcomes sorafenib resistance of hepatocellular carcinoma
Y-C Shen et al.
BRITISH JOURNAL OF CANCER (2013)
Combined Targeting of PDK1 and EGFR Triggers Regression of Glioblastoma by Reversing the Warburg Effect
Kiran Kumar Velpula et al.
CANCER RESEARCH (2013)
Mitochondrial activation by inhibition of PDKII suppresses HIF1α signaling and angiogenesis in cancer
G. Sutendra et al.
ONCOGENE (2013)
Targeting cellular metabolism to improve cancer therapeutics
Y. Zhao et al.
CELL DEATH & DISEASE (2013)
p53 Negatively Regulates Transcription of the Pyruvate Dehydrogenase Kinase Pdk2
Tanupriya Contractor et al.
CANCER RESEARCH (2012)
Inactivation of the HIF-1α/PDK3 Signaling Axis Drives Melanoma toward Mitochondrial Oxidative Metabolism and Potentiates the Therapeutic Activity of Pro-Oxidants
Jerome Kluza et al.
CANCER RESEARCH (2012)
Glucose transporters in cancer metabolism
Kehinde Adekola et al.
CURRENT OPINION IN ONCOLOGY (2012)
Hallmarks of Cancer: The Next Generation
Douglas Hanahan et al.
CELL (2011)
Anticancer drugs that target metabolism: is dichloroacetate the new paradigm?
Ioanna Papandreou et al.
INTERNATIONAL JOURNAL OF CANCER (2011)
Regulation of cancer cell metabolism
Rob A. Cairns et al.
NATURE REVIEWS CANCER (2011)
Dichloroacetate induces apoptosis and cell-cycle arrest in colorectal cancer cells
B. M. Madhok et al.
BRITISH JOURNAL OF CANCER (2010)
Sodium dichloroacetate (DCA) reduces apoptosis in colorectal tumor hypoxia
Siranoush Shahrzad et al.
CANCER LETTERS (2010)
Case Report of a Serious Adverse Event Following the Administration of T Cells Transduced With a Chimeric Antigen Receptor Recognizing ERBB2
Richard A. Morgan et al.
MOLECULAR THERAPY (2010)
Metabolic Modulation of Glioblastoma with Dichloroacetate
E. D. Michelakis et al.
SCIENCE TRANSLATIONAL MEDICINE (2010)
microRNAs: tiny RNA molecules, huge driving forces to move the cell
Shenglin Huang et al.
PROTEIN & CELL (2010)
MicroRNAs in Cancer
Ramiro Garzon et al.
ANNUAL REVIEW OF MEDICINE (2009)
Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation
Matthew G. Vander Heiden et al.
SCIENCE (2009)
Dichloroacetate (DCA) as a potential metabolic-targeting therapy for cancer
E. D. Michelakis et al.
BRITISH JOURNAL OF CANCER (2008)
The genetics of the p53 pathway, apoptosis and cancer therapy
Alexei Vazquez et al.
NATURE REVIEWS DRUG DISCOVERY (2008)
Age-dependent kinetics and metabolism of dichloroacetate: Possible relevance to toxicity
Albert L. Shroads et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2008)
Distinct structural mechanisms for inhibition of pyruvate dehydrogenase kinase isoforms by AZD7545, dichloroacetate, and radicicol
Masato Kato et al.
STRUCTURE (2007)
A mitochondria-K+ channel axis is suppressed in cancer and its normalization promotes apoptosis and inhibits cancer growth
Sebastien Bonnet et al.
CANCER CELL (2007)
Glucose metabolism and cancer
Reuben J. Shaw
CURRENT OPINION IN CELL BIOLOGY (2006)
Cancer's molecular sweet tooth and the Warburg effect
Jung-whan Kim et al.
CANCER RESEARCH (2006)
Diverging regulation of pyruvate dehydrogenase kinase isoform gene expression in cultured human muscle cells
EL Abbot et al.
FEBS JOURNAL (2005)
MicroRNAs: Genomics, biogenesis, mechanism, and function
DP Bartel
CELL (2004)
Efficacy of dichloroacetate as a lactate-lowering drug
PW Stacpoole et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2003)
Recent advances in mechanisms regulating glucose oxidation at the level of the pyruvate dehydrogenase complex by PDKs
MC Sugden et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2003)
Irinotecan plus fluorouracil and leucovorin for metastatic colorectal cancer.
LB Saltz et al.
NEW ENGLAND JOURNAL OF MEDICINE (2000)
Irinotecan combined with fluorouracil compared with fluorouracil alone as first-line treatment for metastatic colorectal cancer: a multicentre randomised trial
JY Douillard et al.
LANCET (2000)
Share Paper
